section name header

Y-Site Injection Compatibility (1:1 Mixture)

Nalbuphine HCl

(Mfr: AST)(Conc: 10 mg/mL)

I

Docetaxel

(Mfr: RPR)(Conc: 0.9 mg/mLa)

Remarks:

Increase in measured subvisible turbidity occurs immediately

Ref:

2224